HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) sold 3.2% of their position (1.63K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $37.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2026ACC: 0001193125-26-089109
Officer· SVP, Chief Accounting Officer
Since Mar 2026
-1.78K
Net shares
Net seller
$40.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
1.78K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−148.00
Price / share
$23.39
Trade value
$3.46K
% of position
0.3%
3/2/2026
50.45K→50.30K
Common Stock
Direct
Shares
−1.63K
Price / share
$22.80
Trade value
$37.21K
% of position
3.2%
3/2/2026
50.30K→48.67K
Total
Net shares
−1.78K
Net value
-$40.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | F · Tax Withholding | −148.00 | $23.39 | $3.46K | 0.3% | 50.45K | 50.30K |
| Common Stock Direct | 3/2/2026 | S · Sale | −1.63K | $22.80 | $37.21K | 3.2% | 50.30K | 48.67K |
| Total | −1.78K | -$40.67K | ||||||
Derivative Transactions0
No derivative transactions reported